Deal watch: Metabolex and Sanofi-Aventis partner on GPCR agonists for type 2 diabetes.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D016503:Drug Delivery Systems; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology*; D043562:Receptors, G-Protein-Coupled / Q000819:agonists*
C519854:GPR119 protein, human; D007004:Hypoglycemic Agents; D043562:Receptors, G-Protein-Coupled
Nat Rev Drug Discov. 2009 May;8(5):369-85
19365392